We evaluated some useful parameters which identify immune-depressive s
tates in the elderly neoplastic patient, who is subject to possible as
sociated infective diseases. Out of 27 patients followed-up over four
months of chemotherapy in concomitance with an immunomodulator, it was
seen that in 42.3% there was an increase in their immune defences, as
sessed by an increase in total lymphocytes with a lymphocyte ratio of
T4/T8 and NK cells, and by checking the urinoculture for urinary infec
tions which showed an improved performance status.